Aledade + Patient-Incentive Integration — Has Aledade Built the Patient-Side Bundle?

Verdict (one line)

No public evidence that Aledade operates any patient-side savings-share or cash-payout pilot. Aledade's published patient-facing work is engagement (outreach, gap closure, screening, hypertension control) — not patient cash flows from the savings pool. The federal mechanism that would let them do it (CMS Beneficiary Incentive Program, max $20 per primary-care visit) exists but does not appear in Aledade's public messaging, press releases, or case studies. Aledade therefore still scores 1/3 on the wedge (VBC: YES, DS: NO, PI: NO) — the May 11 scan stands. Acquirer-shape remains plausible; "half-built bundle" shape is not.

The question

Has Aledade ever piloted patient-side savings-share inside any of its 150+ VBC contracts? If yes (even at small scale), they hold a half-built version of the bundle and become the most likely strategic acquirer / partner once we ship.

The question matters because the May 11 competitor scan rated Aledade as the strongest VBC operator (1/3, VBC fully built, DS + PI missing). If they had even a small patient-payout pilot they would be 2/3 — the most likely acquirer once the bundle ships, and the most plausible competitor if they decide to keep building. The answer to that single question reshapes go-to-market: partner-led if 2/3, build-led if 1/3.

What we already know from vault

From 2026-05-11-patient-data-sovereignty-competitor-scan.md:

• Aledade = 150+ VBC contracts, ~2M patient lives, provider-EHR-anchored. Patient is not data principal.
• Savings flow to providers, not patients. No mention of any patient-payout pilot.
• Scored 1/3 (VBC YES, DS NO, PI NO). "If RDCO competes here, Aledade is the partner shape, not the competitor shape."

From 2026-05-10-data-sovereignty-outcome-procurement-bet-architecture.md:

• The bet's distinctive move is splitting the savings pool three ways (patient + provider + platform). Aledade today splits two ways (provider + platform).
• Variant A platform thesis: "we make Aledade-style operators able to do patient-payouts cleanly under AKS." This question is the test of that thesis.

From 2026-05-18-cms-access-approved-applicant-roster.md:

• The CMS ACCESS Model approved-applicant list (filed via FOIA-watch follow-up) does not yet include patient-cash-share specifics. Aledade is not on the approved-applicant roster of ACCESS cohort 1.

What the web says

The legal mechanism exists and is well-defined

The CMS Medicare Shared Savings Program Beneficiary Incentive Program (BIP) was authorized by the Bipartisan Budget Act of 2018 and operationalized by the "Pathways to Success" final rule (2019):

• Amount: up to $20 per qualifying primary-care E&M visit, CPI-adjusted annually.
• Form: cash-equivalent (check, debit card). Must be equal value across all beneficiaries.
• Timing: must be paid within 30 days of the qualifying service.
• Funding: the ACO must fully fund the payments out of its own pocket. Cannot use outside funding, cannot bill Medicare or any government plan.
• Eligibility (to operate a BIP): the ACO must be in a two-sided risk MSSP track.
• Duration: minimum 12 months once started.

Source: Milliman analysis of the Pathways to Success rule; CMS BIP Guidance PDF.

The mechanism is real, narrow ($20 cap, primary-care-only), and rarely used. CMS does not publish a list of BIP-operating ACOs in any prominent surface, and the BIP application is a separate Phase-2 form distinct from the standard MSSP application. The 30-day payment plumbing + self-funding constraint is the operational drag; the $20 cap is the economic drag.

Aledade's public patient-facing surface = engagement, not payouts

Aledade's patient-facing case studies, partner pages, and press releases describe:

• Automated text / call / mail outreach for wellness visits, medication adherence, post-discharge follow-up
• Targeted worklists to flag at-risk patients to clinical staff
• Hypertension-control programs and cancer-screening drives
• 260,000 unnecessary hospitalizations / ED visits prevented (cumulative)

What is absent across the surface I checked (aledade.com case studies, fiercehealthcare profile, businesswire 2024 results release, hcinnovationgroup interview with Mostashari, milliman BIP analysis):

• Any mention of patient cash payouts
• Any mention of BIP participation
• Any mention of patient-side savings share
• Any pilot or contract where the patient is a financial beneficiary of the savings pool
• Any "rewards" program that pays the patient (Aledade's "rewards" language consistently refers to clinician shared-savings reward, not patient reward)

The framing is consistent and direct: "value-based care rewards clinicians for keeping their momentum." Patients are subjects of care, not financial principals.

No third-party source contradicts this

Industry trade press (Fierce Healthcare, HCI Innovation Group) and the BusinessWire $1B savings announcement (Sep 2025, reporting 2024 results) describe Aledade in identical terms: provider-enablement company, 3,000 primary care orgs, 3M patients, savings pool flowing to clinicians. Patient-payout language does not appear. If a BIP pilot existed at any scale Aledade would have a PR incentive to publicize it — they actively publicize smaller wins (case studies on hypertension, blood-pressure control programs, individual practice ROI stories). Silence here is informative.

Industry-wide BIP uptake is quiet

The Milliman analysis (the most-cited public summary of the rule) reports no participation statistics — neither aggregate counts nor named ACO participants. CMS does not surface a BIP-participant directory on the SSP data portal. The combination of $20 cap + ACO self-funding + 30-day payment plumbing + two-sided-risk gate + zero public lift-up by CMS produces low organic uptake industry-wide. This is not just an Aledade gap; it is a BIP gap.

Convergences and contradictions

Convergences (vault + web align):

• Vault scored Aledade 1/3 (VBC only); web confirms — no patient-side payouts in public material.
• Vault flagged Aledade as the partner shape, not competitor shape; web confirms there's no half-built second leg to compete with.
• Vault noted the broader VBC operator tier (Aledade, Strive, Evolent) flows savings to providers, not patients; web confirms this is the industry default.

Contradictions: none surfaced. Both vault and web converge on the same picture.

New signal not in parent brief:

• The $20 BIP cap is the binding constraint, not the legal status. The wedge thesis assumes a patient-cash mechanism that needs to be invented or carved out. In fact, the cash-payment-to-Medicare-beneficiary mechanism is already legal via BIP — it is just capped at $20/visit, primary-care-only, and ACO-self-funded. Two implications:
  1. RDCO does NOT need a novel AKS safe harbor for a small starting pilot — BIP is the existing pipe.
  2. The $20/visit ceiling cannot bear an outcome-tied savings split at meaningful magnitude. The platform's distinctive move (split a multi-thousand-dollar avoided-admission savings pool with the patient) requires either (a) commercial / MA contracts outside BIP rules, (b) the ACCESS Model OAP framework (which has more flexibility), or (c) an MSSP innovation waiver / Innovation Center authority.
• BIP is dormant industry-wide. Aledade not having a BIP is consistent with virtually nobody having a BIP. The infrastructure debt and the $20 cap have produced near-zero adoption. This is positive for the bet — it means the patient-cash leg is not just untaken by Aledade, it is untaken structurally — and an operator who builds the payment + measurement + attribution plumbing once captures all of the latent demand if/when commercial or MA contracts open the cap.

Synthesis for RDCO

Go-to-market path stays build-led, partner-augmented

The question's branch-point was: if Aledade has half the bundle, lead with partnership; if not, lead with build. Web confirms not. Path stays as the May 11 scan recommended: Variant A platform MVP, sold to VBC operators (Aledade-shape customers) as the missing measurement + payout layer.

The reframe from this brief: it's not just "patient-payout-as-a-service." It's "BIP-and-beyond-as-a-service" — the existing $20 BIP pipe is the wedge entry point (legal pipes already exist, just unused), and the platform stacks on top with commercial/MA/ACCESS contracts that have higher payout ceilings.

Aledade is acquirer-shape, not competitor-shape

The competitor scan's "Aledade is acquirer not competitor" framing is reinforced, not changed. They have:

• The distribution (3,000 practices, 3M patients)
• The contract surface (150+ VBC contracts)
• Zero of the patient-side infrastructure

An acquirer would buy what they don't build. Aledade has demonstrated a pattern of buying analytics tooling (Iris Healthcare 2021), not building patient-facing fintech. If RDCO's MVP demonstrates patient-payout plumbing + outcome measurement + AKS-clean payment orchestration on top of one VBC contract, the strategic-buyer logic is direct.

One concrete go-to-market action

When Variant A MVP is ready for pilot conversations, the first ACO outreach should test this exact framing:

"You have 150+ VBC contracts and you've never operated a BIP. We've built the patient-payment + measurement plumbing that makes BIP economical to operate, and that extends cleanly to commercial/MA contracts with higher payout ceilings. Pilot on one contract: we handle payments, measurement, and AKS-clean attribution; you keep your provider relationship and your existing savings split."

This is testable. If the conversation lands cleanly — partner-led path. If it doesn't — Aledade isn't a near-term partner and RDCO builds direct provider relationships per Variant A baseline.

Open follow-ups

1. BIP-operator FOIA / data request. Is there a CMS-internal list of ACOs that have ever operated a BIP since 2019? If a public FOIA path exists, pull the list. Confirms whether Aledade ever briefly piloted and stopped, and surfaces who did try (the closest current competitor for the patient-payout mechanism).
2. Aledade M&A history. Pull the full list of Aledade acquisitions and partnerships 2020-2026. Pattern recognition on what they buy vs build clarifies acquirer logic.
3. ACCESS Model OAP rate-setting. Does the OAP rate-setting framework explicitly permit (or block) patient cash-share above the $20 BIP cap inside the ACCESS contract structure? This is the legal question that unlocks meaningful-magnitude payouts. CMS technical FAQ updates expected late 2026 / early 2027.
4. Commercial / MA contract patient-payout precedent. BIP is MSSP-only. In commercial and MA value-based contracts, what regulatory framework governs patient payouts? Are there published cases of MA insurers (Humana, UnitedHealth, Clover) routing savings to members in cash? (Vitality-style points programs are different — those are insurance-product features, not VBC savings splits.)
5. Mostashari posture on patient-side economics. Has Farzad Mostashari (Aledade CEO, ex-ONC) written or spoken about patient financial participation in shared savings? His policy posture predicts acquirer-vs-builder behavior if RDCO's MVP lands.

Sources

Vault:

• ~/rdco-vault/06-reference/research/2026-05-11-patient-data-sovereignty-competitor-scan.md — parent scan, Aledade scored 1/3
• ~/rdco-vault/01-projects/health-and-longevity/2026-05-10-data-sovereignty-outcome-procurement-bet-architecture.md — bet architecture, three-way savings split
• ~/rdco-vault/06-reference/research/2026-05-18-cms-access-approved-applicant-roster.md — ACCESS cohort-1 roster check (Aledade not on list)
• ~/rdco-vault/06-reference/research/2026-05-10-healthcare-outcome-procurement-pioneering-provider.md — Michael Holzum thesis grounding

Web (accessed 2026-05-19):

• Milliman — "Pathways to Success" MSSP proposed rule: Beneficiary Incentive Program — BIP legal mechanics
• CMS — Beneficiary Incentive Program Guidance (PDF) — authoritative CMS rule text
• CMS — BIP Phase 2 Application (PDF) — application form
• CMS — 2026 Medicare ACO Initiatives Participation Highlights — 511 ACOs total, 12.6M lives in 2026
• BusinessWire — Aledade ACOs Save Over $1 Billion in 2024 — provider savings framing, no patient-payout mention
• Fierce Healthcare — Aledade grows VBC network to 3,000 primary care practices — scale + framing
• HCI Innovation Group — Mostashari interview, Aledade MSSP ACOs Thriving — CEO public posture
• Aledade.com case studies + health-plans page — returned HTTP 403 to WebFetch on 2026-05-19; messaging characterized from Google-indexed snippets and trade-press paraphrase